English
Segment disclosures
Company overviewHenry Schein, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Intersegment Elimination · Global Distribution And Value Added Services
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-12-28 – 2026-09-26 | -13000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | -3000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | -18000000 | USD | 20260224 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | -13000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | -4000000 | USD | 20250805 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | -8000000 | USD | 20250805 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | -4000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | -31000000 | USD | 20260224 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | -13000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | -21000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | -8000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | -36000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | -22000000 | USD | 20250225 | Open filing evidence |
Intersegment Elimination · Global Specialty Products
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalSpecialtyProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-12-28 – 2026-09-26 | -126000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | -38000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | -155000000 | USD | 20260224 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | -111000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | -40000000 | USD | 20250805 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | -73000000 | USD | 20250805 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | -33000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | -132000000 | USD | 20260224 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | -31000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | -61000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | -30000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | -119000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | -128000000 | USD | 20250225 | Open filing evidence |
Intersegment Elimination · Global Technology
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalTechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-12-28 – 2026-09-26 | 0 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 0 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 0 | USD | 20260224 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 0 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 0 | USD | 20250805 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 0 | USD | 20250805 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 0 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 0 | USD | 20260224 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 0 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 0 | USD | 20250805 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 0 | USD | 20260224 | Open filing evidence |
Operating Segments · North America · Technology
Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 147644000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 399478000 | USD | 20211102 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 120949000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 327374000 | USD | 20211102 | Open filing evidence |
Operating Segments · Global Distribution And Value Added Services
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 2944000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 8694000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 2911000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 5750000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 2839000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 11138000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 2840000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 8247000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 2731000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 5407000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 2676000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 10760000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 2711000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 8058000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 2654000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 5347000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 2693000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 10561000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 10975000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Distribution And Value Added Services · Global Dental Equipment
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;us-gaap:SubsegmentsAxis=hsic:GlobalDentalEquipmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 449000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 1322000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 456000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 873000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 417000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 1799000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 440000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 1263000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 439000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 823000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 384000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 1723000000 Restated | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 417000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 1245000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 426000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 828000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 402000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 1675000000 Restated | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 1715000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Distribution And Value Added Services · Global Dental
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;us-gaap:SubsegmentsAxis=hsic:GlobalDentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 1806000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 5426000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 1854000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 3620000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 1766000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 6868000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 1714000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 5050000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 1715000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 3336000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 1621000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 6679000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 1635000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 4999000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 1696000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 3364000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1668000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 6649000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 6629000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Distribution And Value Added Services · Global Dental Merchandise
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;us-gaap:SubsegmentsAxis=hsic:GlobalDentalMerchandiseMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 1295000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 3924000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 1337000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 2629000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 1292000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 4831000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 1210000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 3613000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 1218000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 2403000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 1185000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 4723000000 Restated | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 1155000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 3579000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 1214000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 2424000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1210000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 4783000000 Restated | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 4763000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Distribution And Value Added Services · Global Medical
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;us-gaap:SubsegmentsAxis=hsic:GlobalMedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 1138000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 3268000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 1057000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 2130000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 1073000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 4270000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 1126000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 3197000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 1016000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 2071000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 1055000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 4081000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 1076000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 3059000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 958000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 1983000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1025000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 3912000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 4346000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Distribution And Value Added Services · Global Value Added Services
Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;us-gaap:SubsegmentsAxis=hsic:GlobalValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 62000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 180000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 61000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 118000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 57000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 238000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 64000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 174000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 58000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 110000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 52000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 233000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 63000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 175000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 56000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 112000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 56000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 191000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 151000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Specialty Products
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalSpecialtyProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 391000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 1207000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 419000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 816000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 397000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 1544000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 369000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 1122000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 386000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 753000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 367000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 1446000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 348000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 1078000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 370000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 730000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 360000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 1331000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 1273000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Global Technology
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalTechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 181000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 535000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 181000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 354000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 173000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 675000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 173000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 502000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 167000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 329000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 162000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 630000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 157000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 470000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 156000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 313000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 157000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 602000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 549000000 | USD | 20250225 | Open filing evidence |
Operating Segments · Healthcare Distribution
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 3009706000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 8606843000 | USD | 20211102 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 2815172000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 5597137000 | USD | 20210803 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 2676999000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 6511865000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 1559102000 | USD | 20210803 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 3834866000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 2815172000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 5597137000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 1559102000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · International
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 809792000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1581847000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 446568000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · North America
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 2005380000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 4015290000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 1112534000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · Dental
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 1910344000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 3699272000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 941292000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · Dental · International
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 782737000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1526882000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 425346000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · Dental · North America
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 1127607000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 2172390000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 515946000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · Medical
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 904828000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1897865000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 617810000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · Medical · International
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 27055000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 54965000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 21222000 | USD | 20210803 | Open filing evidence |
Operating Segments · Healthcare Distribution · Reportable Subsegments · Medical · North America
Consolidation Items · Statement Business Segments · Subsegments Consolidation Items · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 877773000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1842900000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 596588000 | USD | 20210803 | Open filing evidence |
Operating Segments · Technology
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 168609000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 463656000 | USD | 20211102 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 152051000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 295047000 | USD | 20210803 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 138355000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 375547000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 105227000 | USD | 20210803 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 237192000 | USD | 20210803 | Open filing evidence |
Operating Segments · Technology · International
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 20965000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 64178000 | USD | 20211102 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 22154000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 43213000 | USD | 20210803 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 17406000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 48173000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 12300000 | USD | 20210803 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 30767000 | USD | 20210803 | Open filing evidence |
Operating Segments · Technology · North America
Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-03-28 – 2021-06-26 | 129897000 | USD | 20210803 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 251834000 | USD | 20210803 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 92927000 | USD | 20210803 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 206425000 | USD | 20210803 | Open filing evidence |
Operating Segments · Reportable Subsegments · North America · Healthcare Distribution
Consolidation Items · Subsegments Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 2278430000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 6293720000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 2009910000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 2011577000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 4790511000 | USD | 20211102 | Open filing evidence |
Operating Segments · Reportable Subsegments · North America · Healthcare Distribution · Dental
Consolidation Items · Subsegments Consolidation Items · Statement Geographical · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 1114631000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 3287021000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 1044783000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 1008836000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 2413154000 | USD | 20211102 | Open filing evidence |
Operating Segments · Reportable Subsegments · North America · Healthcare Distribution · Medical
Consolidation Items · Subsegments Consolidation Items · Statement Geographical · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 1163799000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 3006699000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 965127000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 1002741000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 2377357000 | USD | 20211102 | Open filing evidence |
Operating Segments · Reportable Subsegments · North America · Technology
Consolidation Items · Subsegments Consolidation Items · Statement Geographical · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-03-27 | 121937000 | USD | 20210504 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 3009706000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 8606843000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 2781965000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 2676999000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 6511865000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 1559102000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 3834866000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · International
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 731276000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 2313123000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 772055000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 665422000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 1721354000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 446568000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 1055932000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · North America
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-03-29 – 2020-06-27 | 1112534000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 2778934000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · Dental
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 1822894000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 5522166000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 1788928000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 1649853000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 4066221000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 941292000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 2416368000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · Dental · International
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 708263000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 2235145000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 744145000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 641017000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 1653067000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 425346000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 1012050000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · Dental · North America
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-03-29 – 2020-06-27 | 515946000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 1404318000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · Medical
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 1186812000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 3084677000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 993037000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 1027146000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 2445644000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 617810000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 1418498000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · Medical · International
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-06-27 – 2021-09-25 | 23013000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 77978000 | USD | 20211102 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 27910000 | USD | 20210504 | Open filing evidence |
| 2020-06-28 – 2020-09-26 | 24405000 | USD | 20211102 | Open filing evidence |
| 2019-12-29 – 2020-09-26 | 68287000 | USD | 20211102 | Open filing evidence |
| 2020-03-29 – 2020-06-27 | 21222000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 43882000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Healthcare Distribution · Medical · North America
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-03-29 – 2020-06-27 | 596588000 | USD | 20200804 | Open filing evidence |
| 2019-12-29 – 2020-06-27 | 1374616000 | USD | 20200804 | Open filing evidence |
Operating Segments · Reportable Subsegments · Technology
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-03-27 | 142996000 | USD | 20210504 | Open filing evidence |
Operating Segments · Reportable Subsegments · Technology · International
Consolidation Items · Subsegments Consolidation Items · Statement Business Segments · Statement Geographical
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-03-27 | 21059000 | USD | 20210504 | Open filing evidence |
International · Corporate Tsa
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-12-26 | 75000000 | USD | 20230221 | Open filing evidence |
International · Health Care Distribution And Technology And Value Added Services
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-12-25 | 3227415000 | USD | 20220215 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 2610000000 Restated | USD | 20230221 | Open filing evidence |
International · Technology And Value Added Services
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 31000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 87000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 28000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 56000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 28000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 25000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 75000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 25000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 50000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 25000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 21000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 67000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 23000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 46000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 23000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 21000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 64000000 | USD | 20221101 | Open filing evidence |
International · Animal Health · Corporate Tsa
Statement Geographical · Subsegments · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:SubsegmentsAxis=hsic:AnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-12-25 | 0 | USD | 20220215 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 75273000 | USD | 20220215 | Open filing evidence |
North America · Corporate Tsa
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-12-26 | 0 | USD | 20230221 | Open filing evidence |
North America · Health Care Distribution And Technology And Value Added Services
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-12-25 | 9173606000 | USD | 20220215 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 7434000000 Restated | USD | 20230221 | Open filing evidence |
North America · Healthcare Distribution
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 8397000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 9003000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 4356000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 2255000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 8613000000 | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 2004000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 2008000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 6987000000 Restated | USD | 20230221 | Open filing evidence |
North America · Health Care Distribution
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 2165000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 6381000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 2099000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 4216000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 2117000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 2178000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 6367000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 2094000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 4189000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 2095000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 2219000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 6575000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 2101000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 4356000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 2255000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 2277000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 6289000000 | USD | 20221101 | Open filing evidence |
North America · Healthcare Distribution · Dental
Statement Geographical · Statement Business Segments · Subsegments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 4500000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 4628000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 2229000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1105000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 4506000000 | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 1129000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 1045000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 3472000000 Restated | USD | 20230221 | Open filing evidence |
North America · Health Care Distribution · Dental
Statement Geographical · Statement Business Segments · Subsegments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 1089000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 3321000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 1129000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 2232000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1103000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 1134000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3447000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 1169000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 2313000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 1144000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 1131000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 3360000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 1124000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 2229000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1105000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 1115000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 3289000000 | USD | 20221101 | Open filing evidence |
North America · Healthcare Distribution · Medical
Statement Geographical · Statement Business Segments · Subsegments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 3897000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 4375000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 2127000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1150000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 4107000000 | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 875000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 963000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 3515000000 Restated | USD | 20230221 | Open filing evidence |
North America · Health Care Distribution · Medical
Statement Geographical · Statement Business Segments · Subsegments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 1076000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 3060000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 970000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 1984000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1014000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 1044000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2920000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 925000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 1876000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 951000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 1088000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 3215000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 977000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 2127000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1150000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 1162000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 3000000000 | USD | 20221101 | Open filing evidence |
North America · Technology And Value Added Services
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 190000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 565000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 186000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 375000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 189000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 185000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 519000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 168000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 334000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 166000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 155000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 469000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 158000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 314000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 156000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 149000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 404000000 | USD | 20221101 | Open filing evidence |
North America · Technology
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 705000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 633000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 314000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 156000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 560000000 | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 131000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 124000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 447000000 Restated | USD | 20230221 | Open filing evidence |
North America · Animal Health · Corporate Tsa
Statement Geographical · Subsegments · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:SubsegmentsAxis=hsic:AnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-12-25 | 0 | USD | 20220215 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 0 | USD | 20220215 | Open filing evidence |
Corporate Tsa
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-12-26 – 2022-12-31 | 0 | USD | 20230221 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 0 | USD | 20230221 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 75000000 Restated | USD | 20230221 | Open filing evidence |
Global Distribution And Value Added Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 2940000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 8681000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 2905000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 5741000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 2836000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 11120000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 2835000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 8234000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 2727000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 5399000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 2672000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 10729000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 2706000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 8032000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 2641000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 5326000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 2685000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 10525000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 10953000000 | USD | 20250225 | Open filing evidence |
Global Distribution And Value Added Services · Eliminations And Reconciling Items
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;srt:ConsolidationItemsAxis=hsic:EliminationsAndReconcilingItemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-29 – 2026-06-27 | -6000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | -9000000 | USD | 20260804 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | -5000000 | USD | 20251104 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | -13000000 | USD | 20251104 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | -4000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | -8000000 | USD | 20260804 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | -5000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | -26000000 | USD | 20251104 | Open filing evidence |
Global Distribution And Value Added Services · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalDistributionAndValueAddedServicesMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | -4000000 | USD | 20261103 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | -5000000 | USD | 20261103 | Open filing evidence |
Global Specialty Products
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalSpecialtyProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 350000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 1081000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 372000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 731000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 359000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 1389000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 331000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 1011000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 346000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 680000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 334000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 1314000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 311000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 980000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 339000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 669000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 330000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 1212000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 1145000000 | USD | 20250225 | Open filing evidence |
Global Specialty Products · Eliminations And Reconciling Items
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalSpecialtyProductsMember;srt:ConsolidationItemsAxis=hsic:EliminationsAndReconcilingItemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-29 – 2026-06-27 | -47000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | -85000000 | USD | 20260804 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | -38000000 | USD | 20251104 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | -111000000 | USD | 20251104 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | -40000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | -73000000 | USD | 20260804 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | -37000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | -98000000 | USD | 20251104 | Open filing evidence |
Global Specialty Products · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalSpecialtyProductsMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | -41000000 | USD | 20261103 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | -38000000 | USD | 20261103 | Open filing evidence |
Global Technology
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalTechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 181000000 | USD | 20261103 | Open filing evidence |
| 2025-12-28 – 2026-09-26 | 535000000 | USD | 20261103 | Open filing evidence |
| 2026-03-29 – 2026-06-27 | 181000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 354000000 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-03-28 | 173000000 | USD | 20260505 | Open filing evidence |
| 2024-12-29 – 2025-12-27 | 675000000 | USD | 20260224 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 173000000 | USD | 20261103 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 502000000 | USD | 20261103 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 167000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 329000000 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-03-29 | 162000000 | USD | 20260505 | Open filing evidence |
| 2023-12-31 – 2024-12-28 | 630000000 | USD | 20260224 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 157000000 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 470000000 | USD | 20251104 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 156000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 313000000 | USD | 20250805 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 157000000 | USD | 20250505 | Open filing evidence |
| 2023-01-01 – 2023-12-30 | 602000000 | USD | 20260224 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 549000000 | USD | 20250225 | Open filing evidence |
Global Technology · Eliminations And Reconciling Items
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalTechnologyMember;srt:ConsolidationItemsAxis=hsic:EliminationsAndReconcilingItemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-03-29 – 2026-06-27 | 0 | USD | 20260804 | Open filing evidence |
| 2025-12-28 – 2026-06-27 | 0 | USD | 20260804 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 0 | USD | 20251104 | Open filing evidence |
| 2024-12-29 – 2025-09-27 | 0 | USD | 20251104 | Open filing evidence |
| 2025-03-30 – 2025-06-28 | 0 | USD | 20260804 | Open filing evidence |
| 2024-12-29 – 2025-06-28 | 0 | USD | 20260804 | Open filing evidence |
| 2024-06-30 – 2024-09-28 | 0 | USD | 20251104 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 0 | USD | 20251104 | Open filing evidence |
Global Technology · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:GlobalTechnologyMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-28 – 2026-09-26 | 0 | USD | 20261103 | Open filing evidence |
| 2025-06-29 – 2025-09-27 | 0 | USD | 20261103 | Open filing evidence |
Health Care Distribution And Technology And Value Added Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-12-26 – 2022-12-31 | 12647000000 | USD | 20230221 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 12401000000 Restated | USD | 20230221 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 10044000000 Restated | USD | 20230221 | Open filing evidence |
Healthcare Distribution
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 11533000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 11924000000 | USD | 20240228 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 2849000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 5849000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 3000000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 11754000000 Restated | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 2814000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 5594000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 2780000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 9530000000 Restated | USD | 20230221 | Open filing evidence |
Health Care Distribution
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 2953000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 8830000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 2922000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 5877000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 2955000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 2952000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8728000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 2907000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 5776000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 2869000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 2891000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 8740000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 2849000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 5849000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 3000000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 3008000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 8602000000 | USD | 20221101 | Open filing evidence |
Healthcare Distribution · Operating Segments · Reportable Subsegments
Statement Business Segments · Consolidation Items · Subsegments Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-06-27 | 3834866000 | USD | 20210803 | Open filing evidence |
Healthcare Distribution · International
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 3136000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 2921000000 | USD | 20240228 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 748000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 1493000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 745000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 3141000000 Restated | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 810000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1582000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 772000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 2543000000 Restated | USD | 20230221 | Open filing evidence |
Health Care Distribution · International
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 788000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 2449000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 823000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 1661000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 838000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 774000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2361000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 813000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 1587000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 774000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 672000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 2165000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 748000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 1493000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 745000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 731000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 2313000000 | USD | 20221101 | Open filing evidence |
Healthcare Distribution · International · Operating Segments · Reportable Subsegments
Statement Business Segments · Statement Geographical · Consolidation Items · Subsegments Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=hsic:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-06-27 | 1055932000 | USD | 20210803 | Open filing evidence |
Healthcare Distribution · International · Dental
Statement Business Segments · Statement Geographical · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-03-27 – 2022-06-25 | 729000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 1452000000 | USD | 20220802 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 783000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1527000000 | USD | 20220802 | Open filing evidence |
Healthcare Distribution · International · Medical
Statement Business Segments · Statement Geographical · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-03-27 – 2022-06-25 | 19000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 41000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 102935000 | USD | 20220215 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 27000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 55000000 | USD | 20220802 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 102347000 | USD | 20220215 | Open filing evidence |
Healthcare Distribution · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-03-27 – 2022-06-25 | 2101000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 8619483000 | USD | 20220215 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 4012000000 | USD | 20220802 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 6986191000 | USD | 20220215 | Open filing evidence |
Healthcare Distribution · North America · Operating Segments · Reportable Subsegments
Statement Business Segments · Statement Geographical · Consolidation Items · Subsegments Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-06-27 | 2778934000 | USD | 20210803 | Open filing evidence |
Healthcare Distribution · North America · Dental
Statement Business Segments · Statement Geographical · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-03-27 – 2022-06-25 | 1124000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 4504243000 | USD | 20220215 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 2174000000 | USD | 20220802 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 3471521000 | USD | 20220215 | Open filing evidence |
Healthcare Distribution · North America · Medical
Statement Business Segments · Statement Geographical · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-03-27 – 2022-06-25 | 977000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 4115240000 | USD | 20220215 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1838000000 | USD | 20220802 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 3514670000 | USD | 20220215 | Open filing evidence |
Healthcare Distribution · Dental
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 7539000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 7473000000 | USD | 20240228 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 1853000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 3681000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1828000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 7544000000 Restated | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 1912000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 3701000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 1789000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 5913000000 Restated | USD | 20230221 | Open filing evidence |
Health Care Distribution · Dental
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 1852000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 5690000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 1924000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 3838000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1914000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 1882000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 5737000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 1957000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 3855000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 1898000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 1785000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 5466000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 1853000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 3681000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1828000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 1823000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 5524000000 | USD | 20221101 | Open filing evidence |
Healthcare Distribution · Dental · Operating Segments · Reportable Subsegments
Statement Business Segments · Subsegments · Consolidation Items · Subsegments Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-06-27 | 2416368000 | USD | 20210803 | Open filing evidence |
Healthcare Distribution · Dental · International
Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 3039000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 2845000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 723000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 3038000000 Restated | USD | 20240228 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 744000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 2441000000 Restated | USD | 20230221 | Open filing evidence |
Health Care Distribution · Dental · International
Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 763000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 2369000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 795000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 1606000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 811000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 748000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2290000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 788000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 1542000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 754000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 654000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 2106000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 729000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 1452000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 723000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 708000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 2235000000 | USD | 20221101 | Open filing evidence |
Healthcare Distribution · Dental · International · Operating Segments · Reportable Subsegments
Statement Business Segments · Subsegments · Statement Geographical · Consolidation Items · Subsegments Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:DentalMember;srt:StatementGeographicalAxis=hsic:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:SubsegmentsConsolidationItemsAxis=us-gaap:ReportableSubsegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-06-27 | 1012050000 | USD | 20210803 | Open filing evidence |
Healthcare Distribution · Medical
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 3994000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 4451000000 | USD | 20240228 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 996000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 2168000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1172000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 4210000000 Restated | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 902000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 1893000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 991000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 3617000000 Restated | USD | 20230221 | Open filing evidence |
Health Care Distribution · Medical
Statement Business Segments · Subsegments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 1101000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 3140000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 998000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 2039000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 1041000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 1070000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2991000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 950000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 1921000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 971000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 1106000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 3274000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 996000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 2168000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 1172000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 1185000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 3078000000 | USD | 20221101 | Open filing evidence |
Healthcare Distribution · Medical · International
Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthcareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 97000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 76000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 22000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 103000000 | USD | 20240228 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 28000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 102000000 Restated | USD | 20230221 | Open filing evidence |
Health Care Distribution · Medical · International
Statement Business Segments · Subsegments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:HealthCareDistributionMember;us-gaap:SubsegmentsAxis=hsic:MedicalMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 25000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 80000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 28000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 55000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 27000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 26000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 71000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 25000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 45000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 20000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 18000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 59000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 19000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 41000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 22000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 23000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 78000000 | USD | 20221101 | Open filing evidence |
Technology And Value Added Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyAndValueAddedServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-06-30 – 2024-09-28 | 221000000 | USD | 20241105 | Open filing evidence |
| 2023-12-31 – 2024-09-28 | 652000000 | USD | 20241105 | Open filing evidence |
| 2024-03-31 – 2024-06-29 | 214000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-06-29 | 431000000 | USD | 20240806 | Open filing evidence |
| 2023-12-31 – 2024-03-30 | 217000000 | USD | 20240507 | Open filing evidence |
| 2023-07-02 – 2023-09-30 | 210000000 | USD | 20241105 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 594000000 | USD | 20241105 | Open filing evidence |
| 2023-04-02 – 2023-07-01 | 193000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-07-01 | 384000000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-04-01 | 191000000 | USD | 20240507 | Open filing evidence |
| 2022-06-26 – 2022-09-24 | 176000000 | USD | 20231128 | Open filing evidence |
| 2021-12-26 – 2022-09-24 | 536000000 | USD | 20231128 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 181000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 360000000 | USD | 20230807 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 179000000 | USD | 20230509 | Open filing evidence |
| 2021-06-27 – 2021-09-25 | 170000000 | USD | 20221101 | Open filing evidence |
| 2020-12-27 – 2021-09-25 | 468000000 | USD | 20221101 | Open filing evidence |
Technology
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 806000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 723000000 | USD | 20240228 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 181000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 360000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 179000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 647000000 Restated | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 153000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 298000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 145000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 514000000 Restated | USD | 20230221 | Open filing evidence |
Technology · International
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember;srt:StatementGeographicalAxis=hsic:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-30 | 101000000 | USD | 20240228 | Open filing evidence |
| 2021-12-26 – 2022-12-31 | 90000000 | USD | 20240228 | Open filing evidence |
| 2022-03-27 – 2022-06-25 | 23000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-06-25 | 46000000 | USD | 20220802 | Open filing evidence |
| 2021-12-26 – 2022-03-26 | 23000000 | USD | 20220503 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 87000000 Restated | USD | 20240228 | Open filing evidence |
| 2021-03-28 – 2021-06-26 | 22000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 43000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-03-27 | 21000000 | USD | 20220503 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 67000000 Restated | USD | 20230221 | Open filing evidence |
Technology · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=hsic:TechnologyMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-03-27 – 2022-06-25 | 158000000 | USD | 20220802 | Open filing evidence |
| 2020-12-27 – 2021-12-25 | 554123000 | USD | 20220215 | Open filing evidence |
| 2020-12-27 – 2021-06-26 | 255000000 | USD | 20220802 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 446830000 | USD | 20220215 | Open filing evidence |
Animal Health · International · Corporate Tsa
Subsegments · Statement Geographical · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=hsic:AnimalHealthMember;srt:StatementGeographicalAxis=hsic:InternationalMember;us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-12-29 – 2020-12-26 | 75273000 | USD | 20210217 | Open filing evidence |
Animal Health · Corporate Tsa
Subsegments · Statement Business Segments
Source dimensions
us-gaap:SubsegmentsAxis=hsic:AnimalHealthMember;us-gaap:StatementBusinessSegmentsAxis=hsic:CorporateTsaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-12-27 – 2021-12-25 | 0 | USD | 20220215 | Open filing evidence |
| 2019-12-29 – 2020-12-26 | 75273000 | USD | 20220215 | Open filing evidence |